• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氟-18α-甲基酪氨酸PET在胶质瘤患者中的临床价值:与氟-18氟脱氧葡萄糖PET的比较

Clinical value of fluorine-18α-methyltyrosine PET in patients with gliomas: comparison with fluorine-18 fluorodeoxyglucose PET.

作者信息

Horiguchi Keishi, Tosaka Masahiko, Higuchi Tetsuya, Arisaka Yukiko, Sugawara Kenichi, Hirato Junko, Yokoo Hideaki, Tsushima Yoshito, Yoshimoto Yuhei

机构信息

Department of Neurosurgery, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma, 371-8511, Japan.

Department of Diagnostic Radiology and Nuclear Medicine, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.

出版信息

EJNMMI Res. 2017 Dec;7(1):50. doi: 10.1186/s13550-017-0298-8. Epub 2017 May 31.

DOI:10.1186/s13550-017-0298-8
PMID:28567708
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5451375/
Abstract

BACKGROUND

We investigated the relationship between metabolic activity and histological features of gliomas using fluorine-18α-methyltyrosine (F-FAMT) positron emission tomography (PET) compared with fluorine-18 fluorodeoxyglucose (F-FDG) PET in 38 consecutive glioma patients. The tumor to normal brain ratios (T/N ratios) were calculated, and the relationships between T/N ratio and World Health Organization tumor grade or MIB-1 labeling index were evaluated. The diagnostic values of T/N ratios were assessed using receiver operating characteristic (ROC) curve analyses to differentiate between high-grade gliomas (HGGs) and low-grade gliomas (LGGs).

RESULTS

Median T/N ratio of F-FAMT PET was 2.85, 4.65, and 4.09 for grade II, III, and IV gliomas, respectively, with significant differences between HGGs and LGGs (p = 0.006). Both T/N ratio (p = 0.016) and maximum standardized uptake value (p = 0.033) of F-FDG PET showed significant differences between HGGs and LGGs. ROC analysis yielded an optimal cut-off of 3.37 for the T/N ratio of F-FAMT PET to differentiate between HGGs and LGGs (sensitivity 81%, specificity 67%, accuracy 76%, area under the ROC curve 0.776). Positive predictive value was 84%, and negative predictive value was 62%. T/N ratio of F-FAMT PET was not correlated with MIB-1 labeling index in all gliomas, whereas T/N ratio of F-FDG PET was positively correlated (r  = 0.400, p = 0.013). Significant positive correlation was observed between T/N ratios of F-FDG and F-FAMT (r  = 0.454, p = 0.004), but median T/N ratio of F-FAMT PET was significantly higher than that of F-FDG PET in all grades of glioma.

CONCLUSIONS

The T/N ratio of F-FAMT uptake has high positive predictive value for detection of HGGs. F-FAMT PET had higher T/N ratio, with better tumor-normal brain contrast, compared to F-FDG PET in both LGGs and HGGs. Therefore, F-FAMT is a useful radiotracer for the preoperative visualization of gliomas.

摘要

背景

我们在38例连续的胶质瘤患者中,使用氟-18α-甲基酪氨酸(F-FAMT)正电子发射断层扫描(PET)与氟-18氟脱氧葡萄糖(F-FDG)PET相比较,研究了胶质瘤的代谢活性与组织学特征之间的关系。计算肿瘤与正常脑的比值(T/N比值),并评估T/N比值与世界卫生组织肿瘤分级或MIB-1标记指数之间的关系。使用受试者操作特征(ROC)曲线分析评估T/N比值在区分高级别胶质瘤(HGG)和低级别胶质瘤(LGG)方面的诊断价值。

结果

F-FAMT PET的T/N比值中位数在Ⅱ级、Ⅲ级和Ⅳ级胶质瘤中分别为2.85、4.65和4.09,HGG和LGG之间存在显著差异(p = 0.006)。F-FDG PET的T/N比值(p = 0.016)和最大标准化摄取值(p = 0.033)在HGG和LGG之间也显示出显著差异。ROC分析得出F-FAMT PET的T/N比值区分HGG和LGG的最佳截断值为3.37(敏感性81%,特异性67%,准确性76%,ROC曲线下面积0.776)。阳性预测值为84%,阴性预测值为62%。在所有胶质瘤中,F-FAMT PET的T/N比值与MIB-1标记指数无相关性,而F-FDG PET的T/N比值呈正相关(r = 0.400,p = 0.013)。F-FDG和F-FAMT的T/N比值之间存在显著正相关(r = 0.454,p = 0.004),但在所有级别胶质瘤中,F-FAMT PET的T/N比值中位数显著高于F-FDG PET。

结论

F-FAMT摄取的T/N比值对检测HGG具有较高的阳性预测价值。与F-FDG PET相比,F-FAMT PET在LGG和HGG中均具有更高的T/N比值以及更好的肿瘤与正常脑对比度。因此,F-FAMT是一种用于胶质瘤术前可视化的有用放射性示踪剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b655/5451375/f1cf70a9dce2/13550_2017_298_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b655/5451375/e497fd026e3e/13550_2017_298_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b655/5451375/83179f0c7c9d/13550_2017_298_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b655/5451375/97f05dfecac4/13550_2017_298_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b655/5451375/dba569e18698/13550_2017_298_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b655/5451375/f1cf70a9dce2/13550_2017_298_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b655/5451375/e497fd026e3e/13550_2017_298_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b655/5451375/83179f0c7c9d/13550_2017_298_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b655/5451375/97f05dfecac4/13550_2017_298_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b655/5451375/dba569e18698/13550_2017_298_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b655/5451375/f1cf70a9dce2/13550_2017_298_Fig5_HTML.jpg

相似文献

1
Clinical value of fluorine-18α-methyltyrosine PET in patients with gliomas: comparison with fluorine-18 fluorodeoxyglucose PET.氟-18α-甲基酪氨酸PET在胶质瘤患者中的临床价值:与氟-18氟脱氧葡萄糖PET的比较
EJNMMI Res. 2017 Dec;7(1):50. doi: 10.1186/s13550-017-0298-8. Epub 2017 May 31.
2
Effects of intratumoral inflammatory process on 18F-FDG uptake: pathologic and comparative study with 18F-fluoro-α-methyltyrosine PET/CT in oral squamous cell carcinoma.肿瘤内炎症过程对 18F-FDG 摄取的影响:口腔鳞状细胞癌 18F-氟-α-甲基酪氨酸 PET/CT 的病理对照研究。
J Nucl Med. 2015 Jan;56(1):16-21. doi: 10.2967/jnumed.114.144014. Epub 2014 Dec 4.
3
One-day protocol for F-FDG and N-ammonia PET/CT with uptake decoupling score in differentiating untreated low-grade glioma from inflammation.用于区分未经治疗的低级别胶质瘤和炎症的 F-FDG 和 N-氨 PET/CT 一日方案与摄取解耦评分。
Rev Esp Med Nucl Imagen Mol (Engl Ed). 2020 Mar-Apr;39(2):68-74. doi: 10.1016/j.remn.2019.08.001. Epub 2020 Jan 28.
4
Prognostic value of metabolic tumor volume of pretreatment F-FAMT PET/CT in non-small cell lung Cancer.治疗前F-FAMT PET/CT代谢肿瘤体积在非小细胞肺癌中的预后价值。
BMC Med Imaging. 2018 Nov 26;18(1):46. doi: 10.1186/s12880-018-0292-2.
5
A new diagnostic marker for differentiating multicentric gliomas from multiple intracranial diffuse large B-cell lymphomas on 18F-FDG PET images.一种用于在18F-FDG PET图像上区分多中心胶质瘤与多发颅内弥漫性大B细胞淋巴瘤的新型诊断标志物。
Medicine (Baltimore). 2017 Aug;96(32):e7756. doi: 10.1097/MD.0000000000007756.
6
F-FDG and F-FAMT PET-derived metabolic parameters predict outcome of oral squamous cell carcinoma.F-FDG 和 F-FAMT PET 衍生的代谢参数可预测口腔鳞状细胞癌的预后。
Oral Radiol. 2019 Sep;35(3):308-314. doi: 10.1007/s11282-019-00377-2. Epub 2019 Feb 18.
7
11C-methionine PET for grading and prognostication in gliomas: a comparison study with 18F-FDG PET and contrast enhancement on MRI.11C-蛋氨酸 PET 对脑胶质瘤分级和预后的评估:与 18F-FDG PET 和 MRI 增强对比的研究
J Nucl Med. 2012 Nov;53(11):1709-15. doi: 10.2967/jnumed.111.102533. Epub 2012 Oct 10.
8
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
9
Clinical significance of ¹⁸F-α-methyl tyrosine PET/CT for the detection of bone marrow invasion in patients with oral squamous cell carcinoma: comparison with ¹⁸F-FDG PET/CT and MRI.¹⁸F-α-甲基酪氨酸 PET/CT 检测口腔鳞状细胞癌骨髓侵犯的临床意义:与 ¹⁸F-FDG PET/CT 和 MRI 的比较。
Ann Nucl Med. 2013 Jun;27(5):423-30. doi: 10.1007/s12149-013-0701-0. Epub 2013 Feb 24.
10
Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.利用18F-FLT PET成像检测脑肿瘤增殖:与18F-FDG的比较。
J Nucl Med. 2005 Jun;46(6):945-52.

引用本文的文献

1
L-3-[F]-Fluoro-α-Methyl Tyrosine as a PET Tracer for Tumor Diagnosis: A Systematic Review from Mechanisms to Clinical Applications.L-3-[F]-氟-α-甲基酪氨酸作为肿瘤诊断的正电子发射断层显像(PET)示踪剂:从机制到临床应用的系统评价
Int J Mol Sci. 2025 Jun 18;26(12):5848. doi: 10.3390/ijms26125848.
2
LAT1-specific PET radiotracers: Development and clinical experiences of a new class of cancer-specific radiopharmaceuticals.LAT1特异性PET放射性示踪剂:一类新型癌症特异性放射性药物的研发与临床经验。
Theranostics. 2025 Jan 2;15(5):1864-1878. doi: 10.7150/thno.99490. eCollection 2025.
3
Reply to the letter regarding "Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients-a report of the PET/RANO group": 18F-fluciclovine and target volume delineation.

本文引用的文献

1
Neuro-oncology: Amino acid PET for brain tumours - ready for the clinic?神经肿瘤学:用于脑肿瘤的氨基酸正电子发射断层扫描——准备好应用于临床了吗?
Nat Rev Neurol. 2016 Jul;12(7):375-6. doi: 10.1038/nrneurol.2016.80. Epub 2016 Jun 10.
2
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.2016 年世界卫生组织中枢神经系统肿瘤分类:概述。
Acta Neuropathol. 2016 Jun;131(6):803-20. doi: 10.1007/s00401-016-1545-1. Epub 2016 May 9.
3
Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.
关于“PET成像对胶质瘤患者放疗计划和监测的贡献——PET/RANO组的报告”的信件回复:18F-氟代脱氧胸苷与靶区勾画
Neuro Oncol. 2021 Aug 2;23(8):1410-1411. doi: 10.1093/neuonc/noab098.
4
Targeted alpha therapy using astatine (At)-labeled phenylalanine: A preclinical study in glioma bearing mice.使用砹(At)标记的苯丙氨酸进行靶向α治疗:对荷胶质瘤小鼠的临床前研究。
Oncotarget. 2020 Apr 14;11(15):1388-1398. doi: 10.18632/oncotarget.27552.
5
New fluoroethyl phenylalanine analogues as potential LAT1-targeting PET tracers for glioblastoma.新型氟乙基苯丙氨酸类似物作为潜在的 LAT1 靶向脑胶质瘤正电子发射断层扫描(PET)示踪剂。
Sci Rep. 2019 Feb 27;9(1):2878. doi: 10.1038/s41598-019-40013-x.
神经肿瘤学反应评估工作组及欧洲神经肿瘤学会关于PET成像在胶质瘤临床应用中的建议
Neuro Oncol. 2016 Sep;18(9):1199-208. doi: 10.1093/neuonc/now058. Epub 2016 Apr 21.
4
Early static (18)F-FET-PET scans have a higher accuracy for glioma grading than the standard 20-40 min scans.早期静态(18)F-FET-PET扫描对胶质瘤分级的准确性高于标准的20-40分钟扫描。
Eur J Nucl Med Mol Imaging. 2016 Jun;43(6):1105-14. doi: 10.1007/s00259-015-3276-2. Epub 2015 Dec 15.
5
Applications of PET imaging of neurological tumors with radiolabeled amino acids.放射性标记氨基酸在神经肿瘤PET成像中的应用。
Q J Nucl Med Mol Imaging. 2015 Mar;59(1):70-82. Epub 2014 Dec 17.
6
System L amino acid transporter LAT1 accumulates O-(2-fluoroethyl)-L-tyrosine (FET).系统L氨基酸转运体LAT1会积累O-(2-氟乙基)-L-酪氨酸(FET)。
Amino Acids. 2015 Feb;47(2):335-44. doi: 10.1007/s00726-014-1863-3. Epub 2014 Nov 11.
7
Letter to the Editor: "The role of imaging in the management of progressive glioblastoma. A systematic review and evidence-based clinical practice guideline" [J Neurooncol 2014; 118:435-460].致编辑的信:“影像学在进展性胶质母细胞瘤管理中的作用。一项系统评价和基于证据的临床实践指南”[《神经肿瘤学杂志》2014年;118:435 - 460]
J Neurooncol. 2014 Dec;120(3):665-6. doi: 10.1007/s11060-014-1594-z. Epub 2014 Aug 24.
8
Biological significance of fluorine-18-α-methyltyrosine (FAMT) uptake on PET in patients with oesophageal cancer.氟-18-α-甲基酪氨酸(FAMT)摄取在食管癌患者 PET 上的生物学意义。
Br J Cancer. 2014 Apr 15;110(8):1985-91. doi: 10.1038/bjc.2014.142. Epub 2014 Mar 25.
9
Intra-individual comparison of ¹⁸F-FET and ¹⁸F-DOPA in PET imaging of recurrent brain tumors.¹⁸F-FET 和 ¹⁸F-DOPA 在复发性脑肿瘤 PET 成像中的个体内比较。
Neuro Oncol. 2014 Mar;16(3):434-40. doi: 10.1093/neuonc/not199. Epub 2013 Dec 4.
10
Value of 11C-methionine PET in imaging brain tumours and metastases.11C-蛋氨酸 PET 在脑肿瘤和转移瘤成像中的价值。
Eur J Nucl Med Mol Imaging. 2013 Apr;40(4):615-35. doi: 10.1007/s00259-012-2295-5. Epub 2012 Dec 12.